SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: Phillipa who wrote (274)12/4/1997 11:30:00 AM
From: D.Lu  Read Replies (1) | Respond to of 670
 
You seem to be in the same boat as a lot of others who bought at higher prices. New management seems geared toward sales. Peter H. Proctor, a dermotologist, has offered valuable clinical insights about the efficacy of Procyte's wound dressing and healing products. Can the management get the products out the door? The results are not in yet.

Trading at near book value, at worst Procyte can just piss away to nothing. Since they still have revenues from contract manufacturing, that may take some time. Management talks of partnering out R & D, but I've seen no announcement of any deals. May you make the right decision!



To: Phillipa who wrote (274)12/4/1997 7:35:00 PM
From: VultureInvest  Respond to of 670
 
You are forgetting one important area of business for the company and that is contract drug production. I forsee strong demand for resources and equipment for this.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News